Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > APEX MOLECULAR LIMITED
Company Information for

APEX MOLECULAR LIMITED

BLOCK 19 ALDERLEY PARK, MERESIDE, ALDERLEY EDGE, CHESHIRE, SK10 4TG,
Company Registration Number
06596885
Private Limited Company
Active

Company Overview

About Apex Molecular Ltd
APEX MOLECULAR LIMITED was founded on 2008-05-19 and has its registered office in Alderley Edge. The organisation's status is listed as "Active". Apex Molecular Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
APEX MOLECULAR LIMITED
 
Legal Registered Office
BLOCK 19 ALDERLEY PARK
MERESIDE
ALDERLEY EDGE
CHESHIRE
SK10 4TG
Other companies in LS2
 
Previous Names
YPROTECH LIMITED16/11/2018
YORKSHIRE PROCESS TECHNOLOGY LIMITED02/07/2015
FAVONIA LTD25/03/2011
Filing Information
Company Number 06596885
Company ID Number 06596885
Date formed 2008-05-19
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/05/2024
Account next due 28/02/2026
Latest return 19/05/2016
Return next due 16/06/2017
Type of accounts SMALL
VAT Number /Sales tax ID GB936131927  
Last Datalog update: 2024-11-05 19:37:39
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for APEX MOLECULAR LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Companies with same name APEX MOLECULAR LIMITED
The following companies were found which have the same name as APEX MOLECULAR LIMITED. These may be the same company in different jurisdictions
  Registered addressLast known statusFormation date
APEX MOLECULAR GENETICS LLC 12273 US 98 MIRAMAR BEACH FL 32550 Inactive Company formed on the 2019-04-17

Company Officers of APEX MOLECULAR LIMITED

Current Directors
Officer Role Date Appointed
PATRICK JOHN MOLYNEUX
 Company Secretary 2017-11-30
STUART ANDREW BROWN
 Director 2016-12-16
ANTHONY FLINN
 Director 2016-09-29
PETER JACKSON
 Director 2008-05-19
THOMAS ERIC OLIVER SCREEN
 Director 2011-06-13
Previous Officers
Officer Role Date Appointed Date Resigned
CHRISTOPHER CASTIEL COLLINS
 Company Secretary 2016-05-10 2017-11-29
SIMON WILLIAM THORN
 Company Secretary 2009-08-01 2016-05-10

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
ANTHONY FLINN INFEX THERAPEUTICS LIMITED Director 2017-07-19 CURRENT 2016-02-05 Active
ANTHONY FLINN ALLEN DESIGN & DEVELOPMENT LTD Director 2012-02-02 CURRENT 2012-02-02 Dissolved 2016-05-17
PETER JACKSON INFEX THERAPEUTICS LIMITED Director 2016-02-05 CURRENT 2016-02-05 Active
PETER JACKSON DWFCO 5 LIMITED Director 2014-05-21 CURRENT 2014-02-20 Dissolved 2016-04-05
PETER JACKSON INTELIA CONSULTING LTD Director 2011-09-09 CURRENT 2011-09-09 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-10-07SMALL COMPANY ACCOUNTS MADE UP TO 31/05/24
2024-02-27CONFIRMATION STATEMENT MADE ON 27/02/24, WITH UPDATES
2024-01-23SMALL COMPANY ACCOUNTS MADE UP TO 31/05/23
2023-06-06CONFIRMATION STATEMENT MADE ON 06/06/23, WITH NO UPDATES
2022-11-04STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 065968850001
2022-11-04MR04 STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 065968850001
2022-10-11SMALL COMPANY ACCOUNTS MADE UP TO 31/05/22
2022-10-11AASMALL COMPANY ACCOUNTS MADE UP TO 31/05/22
2022-06-30CH01Director's details changed for Dr Peter Jackson on 2022-06-24
2022-06-14CS01CONFIRMATION STATEMENT MADE ON 08/06/22, WITH NO UPDATES
2021-09-27AASMALL COMPANY ACCOUNTS MADE UP TO 31/05/21
2021-06-09CS01CONFIRMATION STATEMENT MADE ON 08/06/21, WITH UPDATES
2021-06-08SH0127/09/18 STATEMENT OF CAPITAL GBP 297919
2021-04-13CS01CONFIRMATION STATEMENT MADE ON 03/02/21, WITH NO UPDATES
2021-01-19AP03Appointment of Mr Stephen David Hoskins as company secretary on 2021-01-01
2021-01-19AD01REGISTERED OFFICE CHANGED ON 19/01/21 FROM 2nd Floor Ct3 Wigan Investment Centre Waterside Drive Wigan WN3 5BA England
2021-01-14TM02Termination of appointment of Patrick John Molyneux on 2021-01-01
2020-11-26AASMALL COMPANY ACCOUNTS MADE UP TO 31/05/20
2020-05-11CS01CONFIRMATION STATEMENT MADE ON 03/02/20, WITH NO UPDATES
2020-02-26AASMALL COMPANY ACCOUNTS MADE UP TO 31/05/19
2019-12-19AD01REGISTERED OFFICE CHANGED ON 19/12/19 FROM 28/29 Bridgeman Terrace Wigan WN1 1TD England
2019-05-13CS01CONFIRMATION STATEMENT MADE ON 20/04/19, WITH UPDATES
2019-02-28AASMALL COMPANY ACCOUNTS MADE UP TO 31/05/18
2019-02-25AP01DIRECTOR APPOINTED MR MARK CHARLES WARBURTON
2018-11-16RES15CHANGE OF COMPANY NAME 16/11/18
2018-11-16AD01REGISTERED OFFICE CHANGED ON 16/11/18 FROM 12 the Parks Newton-Le-Willows WA12 0JQ England
2018-10-03SH0116/08/18 STATEMENT OF CAPITAL GBP 306112
2018-10-01RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of allotment of securities
2018-08-22MR01REGISTRATION OF A CHARGE / CHARGE CODE 065968850001
2018-04-20CS01CONFIRMATION STATEMENT MADE ON 20/04/18, WITH NO UPDATES
2018-04-20PSC09WITHDRAWAL OF A PERSON WITH SIGNIFICANT CONTROL STATEMENT
2018-04-20PSC08Notification of a person with significant control statement
2018-04-20PSC09WITHDRAWAL OF A PERSON WITH SIGNIFICANT CONTROL STATEMENT ON 20/04/2018
2018-02-22AA31/05/17 ACCOUNTS TOTAL EXEMPTION FULL
2018-02-06AP03Appointment of Mr Patrick John Molyneux as company secretary on 2017-11-30
2018-02-06TM02Termination of appointment of Christopher Castiel Collins on 2017-11-29
2017-07-12LATEST SOC12/07/17 STATEMENT OF CAPITAL;GBP 260565
2017-07-12CS01CONFIRMATION STATEMENT MADE ON 12/07/17, WITH UPDATES
2017-06-05LATEST SOC05/06/17 STATEMENT OF CAPITAL;GBP 281565
2017-06-05CS01CONFIRMATION STATEMENT MADE ON 19/05/17, WITH UPDATES
2017-06-05AD01REGISTERED OFFICE CHANGED ON 05/06/17 FROM C/O Acceleris Capital Lowry House 17 Marble Street Manchester M2 3AW
2017-03-02RP04SH01SECOND FILED SH01 - 19/06/15 STATEMENT OF CAPITAL GBP 182420.00
2017-03-02RP04SH01SECOND FILED SH01 - 02/04/15 STATEMENT OF CAPITAL GBP 160035.00
2017-03-02RP04SH01SECOND FILED SH01 - 04/04/13 STATEMENT OF CAPITAL GBP 138078.00
2017-03-02RP04SH01SECOND FILED SH01 - 27/03/13 STATEMENT OF CAPITAL GBP 131635.00
2017-03-02RP04SH01SECOND FILED SH01 - 20/02/13 STATEMENT OF CAPITAL GBP 113400.00
2017-03-02RP04SH01SECOND FILED SH01 - 15/10/12 STATEMENT OF CAPITAL GBP 99600.00
2017-03-02RP04SH01SECOND FILED SH01 - 26/06/12 STATEMENT OF CAPITAL GBP 97100.00
2017-03-02RP04SH01SECOND FILED SH01 - 05/04/12 STATEMENT OF CAPITAL GBP 88100.00
2017-03-02ANNOTATIONClarification
2017-02-27AA31/05/16 ACCOUNTS TOTAL EXEMPTION SMALL
2016-12-19AP01DIRECTOR APPOINTED DR STUART ANDREW BROWN
2016-12-01AP01DIRECTOR APPOINTED DR ANTHONY FLINN
2016-10-29LATEST SOC29/10/16 STATEMENT OF CAPITAL;GBP 260565
2016-10-29SH0129/09/16 STATEMENT OF CAPITAL GBP 260565.00
2016-10-28RES01ADOPT ARTICLES 29/09/2016
2016-10-28RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2016-05-26AR0119/05/16 FULL LIST
2016-05-10AP03SECRETARY APPOINTED MR CHRISTOPHER CASTIEL COLLINS
2016-05-10TM02APPOINTMENT TERMINATED, SECRETARY SIMON THORN
2016-02-29AA31/05/15 TOTAL EXEMPTION SMALL
2015-07-02RES15CHANGE OF NAME 01/07/2015
2015-07-02CERTNMCOMPANY NAME CHANGED YORKSHIRE PROCESS TECHNOLOGY LIMITED CERTIFICATE ISSUED ON 02/07/15
2015-06-23LATEST SOC23/06/15 STATEMENT OF CAPITAL;GBP 182705
2015-06-23SH0119/06/15 STATEMENT OF CAPITAL GBP 182705
2015-06-23SH0119/06/15 STATEMENT OF CAPITAL GBP 182705
2015-06-19SH0102/04/15 STATEMENT OF CAPITAL GBP 160035
2015-06-19SH0102/04/15 STATEMENT OF CAPITAL GBP 160035
2015-05-27AR0119/05/15 FULL LIST
2015-04-09AD01REGISTERED OFFICE CHANGED ON 09/04/2015 FROM LEEDS INNOVATION CENTRE 103 CLARENDON ROAD LEEDS LS2 9DF
2015-02-22AA31/05/14 TOTAL EXEMPTION SMALL
2014-09-15MEM/ARTSARTICLES OF ASSOCIATION
2014-07-22RES12VARYING SHARE RIGHTS AND NAMES
2014-07-22RES01ADOPT ARTICLES 13/03/2014
2014-06-03LATEST SOC03/06/14 STATEMENT OF CAPITAL;GBP 138078
2014-06-03AR0119/05/14 FULL LIST
2014-05-02SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2014-01-31AA31/05/13 TOTAL EXEMPTION FULL
2013-06-03AR0119/05/13 FULL LIST
2013-05-13SH0104/04/13 STATEMENT OF CAPITAL GBP 113278
2013-05-13SH0104/04/13 STATEMENT OF CAPITAL GBP 113278
2013-04-11AAMDAMENDED EXEMPTION FULL ACCOUNTS MADE UP TO 31/05/12
2013-03-27SH0127/03/13 STATEMENT OF CAPITAL GBP 106835
2013-03-27SH0127/03/13 STATEMENT OF CAPITAL GBP 106835
2013-02-22RES11DISAPPLICATION OF PRE-EMPTION RIGHTS
2013-02-22RES01ADOPT ARTICLES 11/02/2013
2013-02-22SH0120/02/13 STATEMENT OF CAPITAL GBP 88600
2013-02-22SH0120/02/13 STATEMENT OF CAPITAL GBP 88600
2013-01-24AA31/05/12 TOTAL EXEMPTION FULL
2012-11-02SH0115/10/12 STATEMENT OF CAPITAL GBP 88100
2012-11-02SH0115/10/12 STATEMENT OF CAPITAL GBP 88100
2012-07-10SH0126/06/12 STATEMENT OF CAPITAL GBP 88100
2012-07-10SH0126/06/12 STATEMENT OF CAPITAL GBP 88100
2012-06-11AR0119/05/12 FULL LIST
2012-06-11CH03SECRETARY'S CHANGE OF PARTICULARS / SIMON WILLIAM THORN / 18/05/2012
2012-04-27SH0105/04/12 STATEMENT OF CAPITAL GBP 74500
2012-04-27SH0105/04/12 STATEMENT OF CAPITAL GBP 74500
2012-01-11AA31/05/11 TOTAL EXEMPTION SMALL
2011-09-12AD01REGISTERED OFFICE CHANGED ON 12/09/2011 FROM C/O C/O ACCELERIS LOWRY HOUSE 17 MARBLE STREET MANCHESTER M2 3AW ENGLAND
2011-06-29AP01DIRECTOR APPOINTED DR THOMAS ERIC OLIVER SCREEN
2011-06-14AR0119/05/11 FULL LIST
2011-06-14AD01REGISTERED OFFICE CHANGED ON 14/06/2011 FROM C/O C/O ACCELERIS 9TH FLOOR LOWRY HOUSE 17 MARBLE STREET MANCHESTER M2 3AW
2011-05-05RES13SECTION 175 21/04/2011
2011-05-05RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-05-05SH0121/04/11 STATEMENT OF CAPITAL GBP 30000
2011-04-19SH0128/03/11 STATEMENT OF CAPITAL GBP 30000
2011-04-12AA31/05/10 TOTAL EXEMPTION SMALL
2011-03-25RES15CHANGE OF NAME 22/03/2011
2011-03-25CERTNMCOMPANY NAME CHANGED FAVONIA LTD CERTIFICATE ISSUED ON 25/03/11
2011-03-25CONNOTNOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2010-06-02AD01REGISTERED OFFICE CHANGED ON 02/06/2010 FROM ACCELERIS PLC 11 ST JAMES'S SQUARE MANCHESTER M2 6WH
2010-06-01AR0119/05/10 FULL LIST
2010-02-17AA31/05/09 TOTAL EXEMPTION FULL
2009-08-11RES13APPOINTMENT OF SECRETARY, CHEQUE SIGNATORY, CHANGE OF REGISTERED OFFICE 29/07/2009
2009-08-11287REGISTERED OFFICE CHANGED ON 11/08/2009 FROM 10 BOLTON STREET RAMSBOTTOM BURY LANCASHIRE BL0 9HX UNITED KINGDOM
2009-08-11288aSECRETARY APPOINTED SIMON WILLIAM THORN
2009-06-15363aRETURN MADE UP TO 19/05/09; FULL LIST OF MEMBERS
2008-08-2888(2)AD 25/07/08 GBP SI 9999@1=9999 GBP IC 1/10000
2008-08-06RES04GBP NC 1000/100000 25/07/2008
2008-08-06123NC INC ALREADY ADJUSTED 25/07/08
2008-05-19NEWINCINCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to APEX MOLECULAR LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Share
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against APEX MOLECULAR LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 1
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 1
Details of Mortgagee Charges
We do not yet have the details of APEX MOLECULAR LIMITED's previous or outstanding mortgage charges.
Filed Financial Reports
Annual Accounts
2015-05-31
Annual Accounts
2016-05-31
Annual Accounts
2018-05-31
Annual Accounts
2019-05-31
Annual Accounts
2020-05-31
Annual Accounts
2021-05-31
Annual Accounts
2022-05-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on APEX MOLECULAR LIMITED

Intangible Assets
Patents
We have not found any records of APEX MOLECULAR LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for APEX MOLECULAR LIMITED
Trademarks
We have not found any records of APEX MOLECULAR LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for APEX MOLECULAR LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as APEX MOLECULAR LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where APEX MOLECULAR LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by APEX MOLECULAR LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2014-06-0129420000Separate chemically defined organic compounds, n.e.s.
2014-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-04-0171104900Iridium, osmium and ruthenium, in semi-manufactured forms
2011-09-0129420000Separate chemically defined organic compounds, n.e.s.

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
APEX MOLECULAR LIMITED has been awarded 2 awards from the Technology Strategy Board. The value of these awards is £ 251,166

CategoryAward Date Award/Grant
Manufacture of chiral amines using catalytic and flow processing methods : Collaborative Research and Development 2013-02-01 £ 62,500
CP-STAR - Tethered catylysts: Step-change high purity manufacture of high value pharmaceutical fine chemical and biotechnology products : Collaborative Research and Development 2009-10-01 £ 188,666

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards
The European Union has not awarded APEX MOLECULAR LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.
    Other companies at postcode SK10 4TG